Jan 23, 2026 07:23AM
Jan 22, 2026 12:22PM
Jan 21, 2026 07:07AM
Jan 20, 2026 06:09PM
Jan 20, 2026 04:26PM
Jan 20, 2026 12:30PM
Dec 11, 2025 06:52AM Corvus Pharmaceuticals' (CRVS) Demonstrates Improvements in EASI - Cantor Fitzgerald
Nov 4, 2025 04:17PM
Oct 13, 2025 05:30AM
Aug 7, 2025 04:13PM
Jun 25, 2025 08:02AM
Jun 25, 2025 06:36AM
Jun 12, 2025 07:23AM
Jun 4, 2025 07:01AM Corvus Pharma (CRVS) Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
May 20, 2025 05:33AM
May 12, 2025 05:59AM
May 8, 2025 04:14PM
May 8, 2025 04:03PM
Apr 9, 2025 04:02PM
Mar 26, 2025 06:49AM
Mar 25, 2025 04:01PM Corvus Pharmaceuticals, Inc. (CRVS) Misses Q4 EPS by 6c
Mar 20, 2025 08:03AM
Mar 12, 2025 08:01AM
Jan 13, 2025 07:30AM
Dec 23, 2024 05:34AM
Dec 19, 2024 06:38AM
Dec 18, 2024 08:08AM
Dec 18, 2024 07:33AM Corvus Pharma (CRVS) Falls 15% Following Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Dec 18, 2024 07:30AM
Dec 17, 2024 04:49PM
Dec 17, 2024 04:01PM
Dec 4, 2024 04:06PM
Nov 14, 2024 10:01AM
Nov 13, 2024 01:24PM
Nov 12, 2024 04:03PM Corvus Pharmaceuticals, Inc. (CRVS) Misses Q3 EPS by 49c
Oct 22, 2024 06:05AM
Sep 16, 2024 06:48AM
Sep 10, 2024 08:31AM
Aug 16, 2024 02:59PM
Aug 6, 2024 04:05PM
Aug 1, 2024 08:30AM
Jul 25, 2024 08:34AM Corvus Pharma (CRVS): Publication of Preclinical Data in Science Signaling Demonstrated the Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Treatment of Inflammatory Diseases
Sep 17, 2021 09:28AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All